Trudie Lang

Trudie Lang is a Professor of Global Health Research at the University of Oxford. She specialises in clinical trials research capacity building in low-resource settings. Lang helped to organise the clinical trial for the drug brincidofovir during the 2014 Ebola virus outbreak.

Trudie Lang
Alma materLondon School of Tropical Hygiene and Medicine
Scientific career
FieldsGlobal Health
InstitutionsGlaxosmithkline
University of Oxford
Websitehttps://www.ndm.ox.ac.uk/principal-investigators/researcher/trudie-lang#research

Research career

Lang started her career working in pharmaceutical companies, including Syntex Pharmaceuticals and Glaxosmithkline.[1] She later worked in Kenya as Head of the Kilifi Clinical Trial Facility at the KEMRI-Wellcome Trust Research Programme.[2] Lang then moved to the Nuffield Department of Medicine, University of Oxford, where she is currently Professor of Global Health Research in the Centre for Tropical Medicine and Global Health. She was promoted to Professor in 2014 and is a Senior Research Fellow of Green Templeton College.[3][4]

Her work has focused on improving clinical trials in low and middle-income countries, including training of clinical teams, strengthening regulatory protocols, and resource sharing. In particular, she has sought to improve research on clinical trials in complex situations such as refugee camps, natural disasters, and displacement of populations.[5]

She has led on training and capacity development programmes, including one with Palmer Masumbe Netongo, to support research within the African Coalition for Epidemic Research, Capacity, and Training.[6] She also led on a collaborative project with the University of Liverpool to improve the management of brain infections.[7] In 2014, Lang helped organise a clinical trial for the drug brincidofovir during the Ebola virus outbreak in Liberia.[8] She later helped the World Health Organization evaluate the design of a clinical trial for Ebola disease therapeutics during the 2018 outbreak.[9]

Lang is Director of the Global Health Network, a digital platform for researchers in global health to share knowledge, training, and resources.[10]

Alongside her research, Lang has advised the UK government on various areas of global health. In 2015, she provided evidence to the House of Commons Science & Technology Select Committee inquiry on the UK’s response to Ebola.[11] She highlighted the importance of being prepared to undertake research during emerging outbreaks, and the importance of coordination between research groups. She also provided information about the unique regulatory and approval process for the Ebola clinical trials.

Lang has provided expert opinion in many media outlets on topics including Ebola virus, Zika virus, epidemic management, and SARS-CoV2.[12][13][14] She has advocated for better: clinical trial protocols, training of researchers and coordination between research groups in order to be better prepared for future outbreaks.[15] Lang was cited as a key expert in helping inform the British public during the 2020 SAR-CoV2 pandemic.[16]

She has also engaged in outreach with the wider public, giving talks on malaria and emerging diseases, including Zika and Ebola.[17][18][19]

Clinical research during the 2014 Ebola outbreak

Lang was part of a team of scientists at the University of Oxford developing clinical trials for therapeutics against Ebola. She advocated against randomised controlled trials in this specific outbreak, arguing that this model was not appropriate when there was already mistrust of health systems and people were desperate to access medication. Instead the team wanted to give drugs to all Ebola patients and compare survival rates before and after the trial had started.[20] This was met with conflicting stances from the US FDA, however following a meeting with the WHO, the team’s approach was approved.[21]

Lang took charge of liasing with regulators and the drug company in order to start the trial as quickly as possible.[21] She also briefed US White House officials on the progress of clinical research during the Ebola outbreak.[21] In the end the trial took less than 4 months to be organised, compared to the average 18 months expected for these kind of trials.[15]

gollark: Thanks to experimental UK continental plate disconnection lasers, yes.
gollark: Our immortal god-queen cannot in fact die, so there's no need to worry.
gollark: Brexit is going poorly. The UK is looking to launch into space to cut ties with Europe.
gollark: Probably.
gollark: The UK has *all* the best laws.

References
  1. "Tuesday 5th December 7.30-8.30am at Oxford Examination School". TechTonic. Retrieved 15 March 2020.
  2. "European and Developing Countries Clinical Trials Partnership Newsletter" (PDF). European and Developing Countries Clinical Trials Partnership. August 2008. Retrieved 15 March 2020.
  3. "Notices, Oxford University Gazette". 16 September 2015. Archived from the original on 16 September 2015. Retrieved 15 March 2020.
  4. College, Green Templeton. "Professor Trudie Lang". Green Templeton College. Retrieved 16 March 2020.
  5. "Trudie Lang - Nuffield Department of Medicine". www.ndm.ox.ac.uk. Retrieved 15 March 2020.
  6. "Training & Capacity Building | ALERRT". www.alerrt.global. Retrieved 15 March 2020.
  7. "Events and News". warwick.ac.uk. Retrieved 15 March 2020.
  8. Sifferlin, Alexandra (7 January 2015). "Clinical Trial for Ebola Drug Starts in Liberia". Time. Retrieved 12 July 2020.
  9. "Note for the record: Consultation on Clinical Trial Design for Ebola Virus Disease (EVD)" (PDF). WHO. 26 May 2018. Retrieved 15 March 2020.
  10. "Annual Report 2019 - The Global Health Network". hub.tghn.org. Retrieved 15 March 2020.
  11. "House of Commons - Science in emergencies: UK lessons from Ebola - Science and Technology Committee". publications.parliament.uk. Retrieved 15 March 2020.
  12. team, Reality Check (8 March 2020). "Six coronavirus health myths fact-checked". BBC News. Retrieved 15 March 2020.
  13. Perper, Rosie (15 February 2020). "Hawaii announces its coronavirus tests from the CDC were faulty, and it points to a major gap in treating and stopping the spread of the virus". Business Insider. Retrieved 15 March 2020.
  14. Kelland, Kate (11 January 2016). "After Ebola, 2 Other Tropical Diseases Pose New Threats". Scientific American. Retrieved 15 March 2020.
  15. Kelland, Kate (26 October 2015). "MERS, Ebola, bird flu: Science's big missed opportunities". Fox News. Retrieved 15 March 2020.
  16. McKie, Robin; editor, Observer science (8 March 2020). "The experts who have guided the British public through coronavirus outbreak". The Observer. ISSN 0029-7712. Retrieved 15 March 2020.CS1 maint: extra text: authors list (link)
  17. "StackPath". www.cokethorpe.org.uk. Retrieved 15 March 2020.
  18. "Village Hall Talks - Wootton By Woodstock, Oxfordshire". www.woottontalks.co.uk. Retrieved 15 March 2020.
  19. "Emerging Diseases: From Ebola to Zika Review - Nuffield Department of Medicine". www.ndm.ox.ac.uk. Retrieved 15 March 2020.
  20. Boseley, Sarah; editor, health (6 November 2014). "Experimental Ebola drugs should not be withheld, WHO says". The Guardian. ISSN 0261-3077. Retrieved 15 March 2020.CS1 maint: extra text: authors list (link)
  21. Boseley, Sarah (17 February 2015). "Ebola: the race to find a cure | Sarah Boseley". The Guardian. ISSN 0261-3077. Retrieved 15 March 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.